Showing results (31-40 of 53) with videos related to

Sort By:
Pageof 6
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 18, 2008
Seroreactivity to cutaneous human papillomaviruses among patients with nonmelanoma skin cancer or benign skin lesionsKristin Andersson, Tim Waterboer, Reinhard Kirnbauer, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 5, 2006
Papillomavirus-like particles are an effective platform for amyloid-beta immunization in rabbits and transgenic miceEduardo Zamora, Alessandra Handisurya, Saeed Shafti-Keramat, et al.
Pathogens (Basel, Switzerland)|January 28, 2026
The Controversial Link Between Human Papillomavirus Infection and Esophageal Health: An Exploratory Translational StudyMaximilian Egg, Markus Wiesmüller, Bertram Aschenbrenner, et al.
Vaccine|January 24, 2007
A papillomavirus-like particle (VLP) vaccine displaying HPV16 L2 epitopes induces cross-neutralizing antibodies to HPV11Katharina Slupetzky, Ratish Gambhira, Timothy D Culp, et al.
The Journal of General Virology|July 1, 2011
Inoculation of young horses with bovine papillomavirus type 1 virions leads to early infection of PBMCs prior to pseudo-sarcoid formationBettina Hartl, Edmund K Hainisch, Saeed Shafti-Keramat, et al.
The Journal of Infectious Diseases|August 19, 2007
Cutaneous human papillomaviruses found in sun-exposed skin: Beta-papillomavirus species 2 predominates in squamous cell carcinomaOla Forslund, Thomas Iftner, Kristin Andersson, et al.
Scandinavian Journal of Infectious Diseases|February 26, 2010
Risk of being seropositive for multiple human papillomavirus types among Finnish and Ugandan womenProscovia Bazanya Namujju, Heljä-Marja Surcel, Reinhard Kirnbauer, et al.
The Journal of Investigative Dermatology|June 12, 2013
Efficacy of RG1-VLP vaccination against infections with genital and cutaneous human papillomavirusesChristina Schellenbacher, Kihyuck Kwak, Dieter Fink, et al.
The American Journal of Pathology|December 20, 2008
Expression pattern and subcellular localization of human papillomavirus minor capsid protein L2Zhenhua Lin, Anna V Yemelyanova, Ratish Gambhira, et al.
Frontiers in Immunology|October 20, 2022
Next generation L2-based HPV vaccines cross-protect against cutaneous papillomavirus infection and tumor developmentMelinda Ahmels, Filipe C Mariz, Ilona Braspenning-Wesch, et al.
Pageof 6